Financial Year |
March 31 2023 |
Monetary Funds |
379,344,280.12 |
Held-for-trading Financial Assets |
178,611,650.00 |
Notes Receivable |
-- |
Accounts Receivable |
649,893,854.92 |
Advances to Suppliers |
144,648,834.13 |
Other Receivables |
18,762,536.79 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
972,594,650.48 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
29,584,341.37 |
Total Current Assets |
2,675,425,302.48 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
165,106,498.47 |
Investment Properties |
20,105,206.13 |
Fixed Assetes |
3,711,275,361.50 |
Under-construction Projects |
518,206,719.28 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
466,012,001.54 |
R&D expenses |
-- |
Goodwill |
347,048,819.73 |
Long-Term Deferred and Prepaid Expenses |
27,195,708.02 |
Deferred Income Tax Assets |
70,223,265.89 |
Other Non-Current Assets |
61,246,808.38 |
Sub-Total of Non-Current Assets |
5,421,750,884.33 |
Total Assets |
8,097,176,186.81 |
Short-Term Loans |
1,220,329,675.33 |
Trading Financial liabilities |
921,600.00 |
Notes Payable |
271,366,767.00 |
Accounts Payable |
417,044,376.50 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
29,314,280.89 |
Taxes Payable |
6,740,319.48 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
104,868,418.13 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
249,579,022.72 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
2,344,261,556.69 |
Long-term Loans |
398,156,477.28 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
400,310,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
550,000.00 |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,018,411,543.43 |
Total Liabilities |
3,362,673,100.12 |
Paid-In Capital(Or Share Stock) |
1,761,060,155.00 |
Capital Surplus |
2,584,375,026.34 |
Surplus Reserve |
110,391,556.09 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
343,356,524.18 |
Minority Stockholder's Interest |
3,060,450.27 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,731,442,636.42 |
Owner's Equity(Stockholder's Equity) |
4,734,503,086.69 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
8,097,176,186.81 |